secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001021771-22-000060
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative shareholders approve all proposals, including reincorporation to Nevada
--------------------------------------------------------------------------------

- Elected David Rosa and Francisco Silva as Class II directors; 1.8M and 1.95M shares for, respectively.
- Approved amendments to 2021 Stock Incentive Plan: 1.79M for, 163K against.
- Authorized reincorporation from Delaware to Nevada: 1.95M for, 12K against.
- Non-binding advisory vote approved executive compensation; future vote recommended every three years.
- Ratified Marcum LLP as independent auditor for FY2022: 2.64M for, 16K against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177122000060/0001021771-22-000060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177122000060/form8kdtd11322.htm
  HTML page:      https://secwatch.observer/filing/0001021771-22-000060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer